Fezolinetant Clinical Trials
4 recruitingDrug
Phase 23Phase 32
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
MenopauseMenopause Related ConditionsCardiovascular+1 more
University of Colorado, Denver200 enrolled1 locationNCT06975111
Recruiting
Phase 3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
Hot Flashes
Astellas Pharma Global Development, Inc.540 enrolled117 locationsNCT06440967
Recruiting
Phase 2
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Yale University92 enrolled2 locationsNCT06917313
Recruiting
Phase 2
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
Androgen Deprivation TherapyProstate CA
University of Vermont32 enrolled1 locationNCT06972875